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Ten bromotyrosine alkaloids(1-10) were isolated and characterised from the marine sponge Aplysinella rhax ( de Laubenfels 1954) 
collected from the Fiji Islands, which included one new bromotyrosine analogue, psammaplin P (6)  and two other analogues, 
psammaplins O (5) and 4-bromo-6-carbomethoxy salicylic acid (7), which have not been previously reported from natural sources.  
HRESIMS, 1D and 2D NMR spectroscopic methods were used in the elucidation of the compounds. Bisaprasin, a biphenylic dimer 
of psammaplin A, showed moderate activity with IC50 at 19+/- 5 and 29+/- 6 μM against Trypanzoma cruzi Tulahuen C4, and the 
lethal human malaria species Plasmodium falciparum clone 3D7, respectively, while psammaplins A (1) and D (4) exhibited low 
activity against both parasites. This is the first report of the antimalarial and antitrypanosomal activity of the psammaplin-type 
compounds. Additionally, the biosynthesis hypotheses of the three natural products ( 5, 6 and 7) were proposed.  
Keywords: Psammaplin • Chagas disease • Bromotyrosine• Malaria • Sponge • 
Introduction 
The scourge of tropical diseases caused by kinetoplastid parasites, Plasmodium falciparum and Trypanosoma cruzi has negatively 
impacted the health of a substantial group of the world population living mostly in the developing world and has led to the death 
of millions of people.[1] Chagas disease otherwise refers to as America Trypanosomiasis, is a chronic parasitic infection caused by 
Trypanosoma Cruzi discovered by the Brazilian physician, Carlos Chagas, in 1909. [2] Chagas disease is primarily confined to Latin 
America, and southern parts of North America, but has spread to many developed countries owing to migration.[2-3[ People infected 
with Chagas disease are usually asymptomatic, and one-third of them later develop a chronic form of the disease which can 
manifest as cardiac disease and is the leading cause of morbidity and mortality in affected countries.[2, 4]   The recent infection 
cases reported for malaria and Chagas diseases are estimated to be  228 million and 6-7 million, respectively. [5-6] To make the 
matter worse, the Plasmodium parasite that causes malaria has developed resistance against the current therapeutic drugs 
(Artesunate) and Artemisinin-based combination therapies (ACT), which first emerged on Cambodia–Thailand border. [7-8] despite 
the huge resources channelled into vaccine development,  no vaccine seems to be in view.[9] There is a high demand for an 
affordable and safe drug to help reduce the scourge of infection in the affected countries.[10-11] Enormous progress is being made 
to eradicate these diseases a significant effort of which is concentrated on finding less toxic therapeutic agents against Chagas 
disease. [12] 
Marine Sponges (phylum Porifera) are among the oldest multicellular animals in the world.[13] They are highly diverse and capable 
of biosynthesising a greater variety of natural bioactive natural products than other invertebrate phyla.[14} Investigation of 
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compounds isolated from taxa in the class Demospongiae, order Verongida, confirmed the presence of a high number of nitrogen-
containing secondary metabolites, [15] and in particular, a diverse array of brominated tyrosine derivatives, [16-17] Marine sponges 
have contributed immensely to natural product discovery and were responsible for nearly  30% of all of the secondary metabolites 
produced till date. [18] Compounds isolated from the Verongida showed a wide range of bioactivities such as antifoulant, [19-22] 
anticancer, [23-27] antimicrobial, [28-31] antifungal, [32-33] and enzymatic activities [34-37]  with IC50 values at low micromolar levels.  
Aeroplysinin-I, an optically active bioactive small molecule, was the first brominated metabolite isolated from a sponge Aplysina 
aerophoba (family Aplysinidae) collected from the Mediterranean Sea,[38] and reported to possess moderate inhibition against 
Plasmodium falciparum and Trypanosoma cruzi. [39] Other marine-derived bromotyrosine alkaloids such as Psammaplysina F, H and 
11-hydroxyaerothionin have shown promising antimalarial activities.[40-43] 
In our search for new metabolites from marine sources against these diseases, the methanolic extract of the sponge Aplysinella 
rhax, collected from the Fiji Islands was subjected to sequential fractionation and purification, indicating that 3 of the 10  
compounds have now been isolated for the first time from natural sources. Herein we report the structure elucidation of the three 
marine-derived compounds and antiparasitic activities of most of the compounds isolated (1-7, 9-10). 
Results and Discussion 
The marine sponge extract was partitioned between water and dichloromethane (50% v/v) using a modified Kupchan method[44] 
previously described[45-46] and further fractionated using reversed-phase solid-phase extraction (SPE). The resulting fractions were 
purified on reversed-phase HPLC to yield psammaplins A (1),[16, 47, 48-50]  B-D(2-4),[16, 49] O (5) and P (6), 3-bromo-2-hydroxyl-6-
carbomethoxy benzoic acid (7), 2-(3-bromo-4-hydroxyphenyl)acetonitrile (8),[16, 50] 3-bromo-4-hydroxybenzoic acid (9),[51] and 
bisaprasin (10)[47-48-50] . All known compounds were identified by comparison of experimental NMR and HRESIMS data with those 
published. 
 
Figure 1. Structure of compounds 1-10 
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Compound 5 was obtained as yellowish oil. High-resolution electrospray ionisation mass spectroscopy HRESI-TOF-MS revealed a 
protonated 1:1 isotopic cluster indicating the presence of one bromine atom at m/z 380.9746/382.9725 [M+H]+ in accordance 
with the molecular formula of C11H14BrN2O6S, requiring 6 degrees of unsaturation (See fig. S21). 
The 1H, 13C and HSQC data of 5 (Table 1) showed the presence of five quaternary carbons, three methylene and three methine 
groups. Detailed analysis of 1H chemicals shifts, coupling constants, and COSY data suggested the presence of a 1,3,4 trisubstituted 
aromatic ring with H-13 (δH 7.07) coupling to both H-12 (δH 6.76, J = 8,4 Hz), and H-9 ( δH 7.36, J = 2.0 Hz). The position of the 
methylene singlet H-7 was deduced from HMBC correlations to C-9 (δC 134.3), and C-13 (δC 130.2) in the aromatic ring, C-6 (δC 
151.3, oxime), and C-5 (δC 165.4, carboxamide) units. The unusual 13C downfield chemical shift for the CH2 group at C-2 (δC 50.8 
ppm) suggested it was attached to the resonance stabilised electron-withdrawing sulfonate group at this position (Fig. 2). Similar 
chemical 13C chemical shifts can be found for psammaplin C [16] that contains the SO2NH2 group at C-2 instead of SO2OH as in 5. 
All 1H, HSQC, COSY, and  HMBC (Figs. 2 and S22-27, Table 1and S63) data were consistent with published data for psammaplin 
type molecules[16] suggesting that the structure of 5 was correct. Even though this article represents the first report of compound 
5 from marine sources, it has been previously described as a semisynthetic product obtained through MCPBA-mediated oxidation 
of psammaplin I. [52]  The NMR data of 5 were consistent with those reported for the semisynthetic version providing further 
evidence for the structure of 5. 
The molecular mass of compound 6 was determined by high-resolution ESI-TOF-MS as 494.0065 [M+H]+ corresponding to a 
molecular formula of C16H20BrN3O6S2, requiring 8 degrees of unsaturation (Figs. S28-S29). Analysis of 1D and 2D NMR data (Tables 
1 & S63, Figs. 1, S30-35) suggested that the general backbone for 6 was essentially that of psammaplin F [50] with the exception of 
the presence of an O-methyl group in 6 to form an ester. The presence of protonated and sodium adducts at m/z 274.9545 (M+H)+ 
and 296.9364 (M+Na)+ in the ESI-TOF spectrum of 7 suggested a molecular formula of C9H7BrO5, requiring 6 degrees of 
unsaturation (Figs. S36-S37). It also displayed the same isotopic pattern shown by 5 indicating the presence of one bromine atom 
in the structure of 7. 
Table 1. 1H and 13C N.M.R. spectroscopy data for 5, 6 and 7 in CD3OD 
 
                           5                                                                           6                                                                           7 
Position δC, type[a] 1H, mult. (J in Hz)[b] δC, type[a] 1H, mult. (J in Hz)[b] δC, type[a] 1H, m (J in Hz)[b] 
1     171.4, C  
2 50.8, CH2 2.98, t (6.6) 37.4, CH2 2.86, t (6.6) 114.4, C  
3 35.8, CH2 3.67, t (6.6) 39.2, CH2 3.57, t (6.6) 162.3, C  
4     110.2, C  
5 165.4, C  165.6, C  138.4, CH 8.30, d (2.1) 
6 151.3, C  152.8, C  121.2, C  
7 28.2, CH2 3.79, s 28.3, CH2 3.81, s 131.8, CH 8.50, d (2.1) 
8 130.3,C  130.2, C  165.2, C  
9 134.3, CH 7.36, d (2.0) 134.2, CH 7.38, d (2.0) 51.1, CH3 3.89, s 
10 109.6, C  110.3, C    
11 152.4, C  153.5, C    
12 116.7, CH 6.76, d (8.4) 116.8, CH 6.79, d (8.4)   
13 130.2, CH 7.07, dd (8.4, 2.0) 130.2, CH 7.09, dd (8.4, 2.0)   
2’   38.2, CH2 2.86, t (6.6)   
3’   39.5, CH2 3.57, t (6.6)   
5’   158.9, C    
6’   161.6, C    
7’   53.3, CH3 3.88, s   
[a] Measured at 150 MHz for 13C-NMR data and [b] measured at 600 MHz for 1H-NMR data in CD3OD 
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Figure 2. Selected COSY and HMBC correlations for 5, 6 and 7 
Analysis of 13C and HSQC data (Table 1, Figs. S39) showed the presence of six quaternary carbons, one methoxy group, while 1H 
NMR and COSY data (Figs. S38 and S40) suggested the presence of a 1,2,3,5 tetrasubstituted aromatic spin system. The 2.1 Hz 
coupling of H-5 to H-7 suggested their meta relationship.  HMBC correlations between H-5 (δH 8.30) and H-7 (δH 8.50) to C-6 and 
C-8, and between H-9 (δH 3.89) and C-8 confirmed the placement of the methyl ester functionality at C-8. (Figs. 2, S41, Table 1 
and S63). There is  HMBC strong correlation between both H-5 and H-7 to the oxygenated carbon C-3 (δC 162.3) and from H-7 to 
C-1 ( δC 171.4). The resonance signal δC 110.2 assigned to C-4  was suggestive of the shielding effect of the bromine atom [53] 
consistent with the brominated carbon C-10 in both 5 and 6 (See table 1). The structure of 7 was determined by assigning the 
hydroxyl group and carboxylic acid substituent to C-3 and C-1, respectively, based on HMBC correlation and chemical shift. 
Interestingly, compound 7 was previously synthesised [54-55], and there was only 1H NMR information available in the literature 
[55]and was consistent with the data obtained for  7. 
 
 
Scheme 1. The proposed biosynthetic hypotheses of 5, 6 and 7. ROS (reactive oxygen species), RNS (reactive nitrogen species). 
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The stereochemistry of the oxime groups is assigned as E for compounds 5 and 6 based on 13C and 1H data. This is in accordance 
with the model carried out by Arabshahi and Schmitz[47] where 13C chemical shifts of the benzylic carbons varied diagnostically 
with geometry. The modified bromotyrosine and cysteine are the basic structural scaffold of psammaplin A and other derivatives 
isolated from the sponge extract and the biosynthetic pathway of psammaplin type compounds have been extensively studied. [16, 
50]  
 As predicted by Pina and co-workers,[16] the logical precursor for the biosynthetic origin of 8 and 9 was the modification of tyrosine 
through condensation, decarboxylation process and subsequent oxidation of 3-bromo-4-hydroxylbenzaldehyde. [50] Based on this 
prediction, the biosynthetic hypothesis of 7 was proposed to be through further methylation of 9, followed by carboxylation 
process (Scheme 1). Psammaplin P (6) was undoubtedly an esterified derivative of psammaplin F, the biosynthetic pathway of 
which was proposed to have originated from the formation of cystine [16]  intermediate through oxidation of a dimerised cysteine 
modification possibly catalysed by cytochrome P450 enzymes in union with bromotyrosine units via a condensation reaction,[50]  
followed by methylation of the carboxylic acid functionality (Scheme 1).  
On the other hand,  compound 5 (Scheme 1) can be rationalised by the reaction of rearranged cysteine as proposed by Jimenez 
and Crews [50] with bromotyrosine to form the bromotyrosinecysteine unit containing a reactive thiol nucleophile (-SH) that 
undergoes oxidation via reactive oxygen species (ROS) and reactive nitrogen species (RNS) to form sulphenic acid(-SOH) as an 
intermediate reacting further to form sulfinic acid (-SO2H) and sulfonic acid (-SO3H).[56-57] Cysteine is very susceptible to oxidative 
enzymatic reactions owing to the electron-rich sulfur atom in its side chain.  This mechanism is well established in bacteria, [57] 
although the link between psammaplin biosynthesis and bacteria has not been proven to date, there is strong evidence of the 
presence of metabolite producing microbes (Poribacteria) living in association with Verongida sponges such as Pseudoceratina 
purpurea [58-59] which produces psammaplins. [16, 47, 48-50]  
 
Table 2. In vitro biological activity of antiparasitic assays  for 1-10                               
 
Compounds 1-6, 9, and 10 were evaluated for their antiparasitic activity against T. cruzi Tulahuen C4, and P. falciparum 3D7 strains. 
Bisaprasin (10), a biphenylic dimer of psammaplin A, showed moderate activity with IC50 at 19 and 29 μM, respectively, while 
psammaplin A (1) showed activity at 30 and 60 µM for the two respective parasites. Besides, Psammaplin D (4) exhibited a lower 
level of activity in the two assays, but the rest of the compounds did not show activity. All compound activities are shown in Table 
IC50 M 
Compounds T.  cruzi C2C4 strain P. falciparum 3D7 
1 30+/- 2 60+/- 2 
2 >35 >70 
3 >66 >131 
4 43+/- 2 67+/- 3 
5 >33 >66 
6 >32 >64 
7 >45 >91 
8 NT NT 
9 >57 >115 
10 19+/- 5 29+/- 6 
Benznidazole[a] 2.6+/- 0.5 NA 
Chloroquine[b] NA 0.017+/- 0.002 
[a] Benznidazole as standard for T. cruzi C2C4 strain. [b] Chloroquine as standard for P. falciparum 3D7 strain. NT and NA represent 
‘not tested’ and ‘not applicable’, respectively. 
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2, including the results for the two standard compounds benznidazole and chloroquine ( Figs. S61-S62). The observed activities 
could be classified as low to moderate when compared to the two standard compounds. 
 
Conclusions 
In conclusion, three bromotyrosine derivatives structurally related to the psammaplin family have been structurally characterised 
where two of the compounds (5 and 7) have now been isolated for the first time from the marine sponge, Aplysinella rhax. These 
three compounds present a new finding that contributes further in widening the chemical space of this family of interesting 
bioactive molecules. Additionally, this study has identified bromotyrosine compounds as potential molecular architectural 
‘signboards’ for new antiparasitic agents. Our results are in line with a recent study on two new bromotyrosine compounds isolated 
from an Australian marine sponge that showed potent activity against malarial parasites.[60] After all, nature has continued to inspire 
drug discovery in this field as out of the 15 compounds used against parasites between 1981-2014, 9 have their origins in natural 
products.[61] 
 
Experimental Section 
General Experimental Procedures 
UV spectra were recorded on an Agilent 1200 HPLC system coupled to a photodiode array detector (DAD). IR spectra were 
recorded on a PerkinElmer UATR Two, model L1600300. Both 1D and 2D NMR data were recorded on a Bruker AVANCE III HD 
Prodigy TCI. cryoprobe  at 600 and 150 MHz for 1H and 13C, respectively. 1H and 13C chemical shift were referenced to the solvent 
peak at 3.31 and 49.1 ppm (CD3OD) respectively. HRESIMS data were obtained using a ThermoScientific LTQ XL/LTQ Orbitrap 
Discovery  coupled to a Thermo instrument Accela HPLC system, and an Agilent 6540 HRESI-TOF-MS coupled to an Agilent 1200 
HPLC system. Fractionations were carried out on solid-phase extraction columns using C18-E (Phenomenex, 55 µm, 70 Å, 2 g/12 
mL, giga tubes). Purification was done on an Agilent 1200 semi-preparative HPLC system equipped with binary pump, photodiode 
array detector (DAD)22, Waters Sunfire reversed-phase column C18 (5µm 10 × 250 mm) and Agilent Zorbax C18 (5 µm 9.4×250 
mm), and a mobile phase solvent gradient between 95:5% and 20:80% ((H2O-MeOH).  
 
Collection and Identification 
The sponge sample was collected from the Fiji Islands in December 1997, freeze-dried and stored in 4 °C. It was identified as 
Aplysinella rhax by Dr. John Hooper of the Queensland Centre for Biodiversity, Queensland Museum, Australia as described in a 
previous publication.[49] A voucher specimen (Voucher number: 9712SD130) is held at the Pacific Regional Herbarium at the 
University of the South Pacific, Suva, Fiji Islands. 
 
Extraction and Isolation 
The sponge sample was extracted with MeOH (3× 300 mL) followed by DCM (3× 200 mL), dried and partitioned following the 
modified Kupchan liquid-liquid partitioning technique described previously.[44] The four fractions (WB, FM, FD and FH) were dried 
and weighed. The FD fraction (0.152 g) was further fractionated on a C-18 SPE using aqueous methanol (25%, 50%, 100% and 
100%MeOH with TFA) as the mobile phase yielding two interesting fractions: FD-100%MeOH (80 mg) and FD50%MeOH (52.6 mg) 
based on 1H NMR profiles. The fraction FD-100%MeOH was purified on a Sunfire reversed phased column using a gradient solvent 
system from 80:20 to 0:100% H2O/MeOH as mobile phase in 30 min to obtain compounds 1 (5.4 mg), 6 (1.3 mg) and 10 (5.8 mg). 
Using the same gradient system, FD-50%MeOH was purified to yield compounds 5 (0.5 mg), 2 (1.2 mg), 3 (3.2 mg), 4 (4.3 mg) and 
8 (0.1 mg). Fractions FM and FB were fractionated by SPE. Using the conditions described for the FD fraction with the WB-
25%MeOH purified further by reversed-phase HPLC to yield compounds 7 (1.3 mg) and 9 (2.9 mg).  
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Psammaplin O (5). Yellowish oil; 0.5 mg; UV (MeOH-H2O) λmax (log ϵ) nm, 221 (3.72), 282 (3.14); IR (MeOH cm-1) 3312, 1660, 1538, 
1494, 1330, 1144; 1H, 13C, and 2D NMR data (CD3OD) are given in Table 1, Table S63 and figs. S22-S27.  HRESIMS m/z 380.9746 
[M+H]+ (Fig. S21).  calculated for C11H14BrN2O6S, 380.9751, Δ = -0.26 ppm. purity of 5 was 97% based on proton NMR baseline 
peak analysis 
Psammaplin P (6). Yellowish oil; 1.3 mg; UV (MeOH-H2O) λmax (log ϵ) nm, 218 (3.66), 230 (3.73), 281 (3.30); IR (MeOH cm-1) 3197, 
2953, 2869, 1691, 1575, 151, 1384, 1296, 1212; 1H, 13C, and 2D NMR data (CD3OD) are given in Table 1, Table S63 and figs. S30-
S35. HRESIMS m/z 494.0065 [M+H]+(figs. S28-S29). calculated for C16H21BrN3O6S2, 494.0050, Δ = -2.8 ppm. Purity of 6 was 95% 
based on 1H NMR baseline peak analysis 
3-Bromo-2-hydroxy-5-(methoxycarbonyl)benzoic acid (7). Yellowish oil; 1.3 mg; UV (MeOH-H2O) λmax (log ϵ) nm, 227 (3.61), 258 
(3.13), 312 (2.79); IR (MeOH cm-1) 3400, 2800, 1703, 1300; 1H, 13C, and 2D NMR data (CD3OD) are given in Table 1, Table S62 and 
fig.  HRESIMS m/z 274.9542 [M+H]+ (Figs. S36-S37). calculated for C9H8BrO5, 274.9550, Δ = -1.81 ppm. Purity of 7 was 97%  based 
on baseline peaks analysis.   
 
β-D-Galactosidase Transgenic Trypanosoma Cruzi in Vitro Assay.  
The T. cruzi Tulahuen C2C4 strain, expressing the βgalactosidase gene (LacZ) and L6 rat skeletal muscle cells used as host cells 
were cultured in RPMI-1640 supplemented with 10% iFBS, 2 mM L-glutamine, 100 U/mL penicillin, and 100 µg/mL streptomycin 
at 37 °C and 5% CO2. T. cruzi amastigote infected L6 cell culture (2 × 103 infected L6 cells per well) were dispensed into 384-well 
assay plates already containing 5 µL of the compounds (1-6, 9-10). Each compound was tested at least in duplicate using 16 points 
dose-response curves (1/2 serial dilution), and the starting concentrations were between 31 µM and 66 µM. The plates were 
incubated at 37 oC for 96 h. 1.5 µL of 100 µM CRPG and 0.1% NP40 diluted in PBS were subsequently added, and plates were 
further incubated at 37 oC for 4 h in the dark after which an Envision plate reader (PerkinElmer, Waltham, MA) was used to measure 
the absorbance at 585nm. The assay was normalised by using the in-plate benznidazole at 10 µg/mL as negative control and 
0.167% DMSO as positive growth control. The method employed in this assay was previously reported by Annang and co-
workers.[62]  
 
Plasmodium Falciparum 3D7 Lactase Dehydrogenase in Vitro Assay. 
 P. falciparum 3D7 strain parasites were cultured in a freshly type 0 positive (0+) human erythrocyte (Centro Regional de 
Transfusiones Sanguíneas-Biobanco, Granada) and the preparation for the assay was enabled by using the standard method 
previously described in 2016 by Pérez-Moreno and co-workers.[63] The compounds ( 1-6, 9-10) were `tested at least in duplicate 
using a 16 points dose-response curve (1/2 serial dilution) with starting concentrations between 63 and 115 µM in 384-well plates. 
Each plate contained a parasite culture medium as a positive growth control and 100 nM of chloroquine as the negative control. 
The plates were incubated for 72 h after which they were frozen for 4 h and thawed at room temperature for 1h. before LDH. 
activity was measured. To do this, 70 µL of freshly prepared solution containing 143 mM Sodium L-lactate, 143 µM APAD,178.75 
µM NBT, 1 µg/mL diaphorase, 0.7% Tween 20, and 100 mM Tris-HCL (pH 8.0) were added into the plates. Absorbance was 
measured at 650 nm after gently shaking the plates to ensure homogeneity and 10 mins incubation at room temperature. The 
Envision plate reader (Perkin Elmer,Waltham MA) was used to measure the absorbance in this assay.  
 
Supplementary Material  
Appendix and Supplementary data related to this article can be found at http://dx.doi.org/10.1002/MS-number 
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